Disclosure UK

The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.

It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.

This information will be published on the database - Disclosure UK.

Disclosure UK database

Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.

Search the Disclosure UK database

Explore the data further

As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.

Methodological notes by company and year

What is Disclosure UK?

This video explains how the Disclosure UK database works, and how it fits into wider frameworks which manage conflicts of interest and support ethical and transparent collaboration between healthcare professionals, healthcare organisations, and the pharmaceutical industry.

The pharmaceutical industry works with healthcare professionals and organisations to develop medicines and deliver them to patients.

These relationships are vital to share knowledge to improve patient care.

Many healthcare professionals and organisations receive payments for their time and expertise.

It is vital these relationships are transparent.

So the pharmaceutical industry has taken the lead and created Disclosure UK - a publicly accessible online database which gives details of these payments and benefits in kind, known as 'transfers of value'.

Disclosure via Disclosure UK is mandatory for all companies abiding by the ABPI Code of Practice for the pharmaceutical industry.

Each year companies submit data from the previous calendar year, which is published at the end of June.

Disclosure UK allows visitors to explore the data which is split into two groups:

Research and development, or R&D activities, which includes everything from medicine's discovery work through to clinical trials in patients
And non research and development, non R&D activities, which are published against individually named people and organisations and broken down into further categories
Activities could include: consultancy, educational grants, and collaborative working for the benefit of patients

This data makes up the core purpose of Disclosure UK.

Disclosure UK also hosts disclosure gateways which allow visitors to find information about transfers of value made to other recipients working with industry: patient organisations and the public, including journalists.

Disclosure UK goes above and beyond European requirements for transparency in the pharmaceutical industry and the UK is among 36 countries committed to open and ethical ways of working.

Disclosure requirements have evolved over time, making Disclosure UK one of the most comprehensive systems in Europe.

However, transparency through Disclosure UK alone does not eliminate the risk of conflicts of interest.

Disclosure UK operates within a broader regulatory framework designed to ensure ethical collaboration between the pharmaceutical sector and healthcare providers.

Together, these frameworks help to ensure ethical transparent collaborations with the pharmaceutical industry that improve care for patients.

We will continue to support transparency through Disclosure UK.

2026 timeline for 2025 disclosure data

For pharmaceutical companies abiding by the ABPI Code of Practice

HCP and Hospital icons

Full disclosures about healthcare professionals, other relevant decision makers, and healthcare organisations must be submitted to Disclosure UK by:

14:00 BST, Tuesday 31 March 2026

Data submission deadline

Ribbon

Gateway links to disclosure information about patient organisations and members of the public must be submitted to Disclosure UK by:

Tuesday 23 June 2026

Gateway links submission deadline

Globe

Disclosure data and links submitted for 2025 will be published together at the end of June:

Tuesday 30 June 2026

Publication

See also, the ABPI Code of Practice and supplementary information to clause 31.1 regarding disclosure timelines.

European Disclosure Gateway

To improve access to European data, the pharmaceutical industry has voluntarily created this single point of access to help any interested stakeholder navigate the publicly available data across all EFPIA Members countries whether hosted on individual company websites or centralised on national platforms.

Open the European Disclosure Gateway

About Disclosure UK

Disclosure UK is an industry-led initiative to deliver a searchable database that shows payments and benefits in kind made by the pharmaceutical industry to doctors, nurses and other health professionals and organisations in the UK.

Resources

The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.

Privacy Notice - Disclosure

The ABPI is committed to protecting and respecting the privacy of your personal data. This privacy notice explains how your data is collected, used, transferred and disclosed by us.